Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Deep vein thrombosis Stories

2014-04-11 23:01:36

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who allegedly suffered dangerous episodes of internal bleeding due to Pradaxa. New York, New York (PRWEB) April 11, 2014 As thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in federal court, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has approved a new indication for the blood thinner. According to an April 7th announcement from Boehringer...

2014-04-08 23:01:01

Dr. Revana, at Northeast Houston Vein Center, is working to educate his peers on the challenging diagnosis of pelvic congestion syndrome as well as other conditions affecting veins. Humble, TX (PRWEB) April 08, 2014 Northeast Houston Vein Center recently began working to educate doctors on the issue of pelvic congestion syndrome (PCS) and other vein issues. Dr. Madaiah Revana is leading the effort on spreading the word about this tough condition. The facility now provides training to...

2014-04-08 12:31:49

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-07 08:31:34

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 7, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-01 23:31:09

The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) April 01, 2014 The birth control safety center DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. The most recent court records indicate the number of lawsuits alleging blood clot side effects dropped for the month of March*. DrugNews is a free...

2014-03-31 08:29:45

RARITAN, N.J., March 31, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today it is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO(®) (rivaroxaban), the most studied and broadly indicated oral Factor Xa inhibitor in the world today. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient...

2014-03-28 08:22:23

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/xvt3hx/investigation ) has announced the addition of the "Investigation Report on China Enoxaparin Sodium Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of...

2014-03-25 23:36:20

The DrugNews Center is the web’s most comprehensive source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) March 25, 2014 The birth control safety advocates at DrugNews.net are alerting those women who have taken the oral contraceptives Yaz or Yasmin of the latest Yaz report on the site. Court records for March show the number of lawsuits alleging the drugs caused side effects like blood clots decreasing as the number of...

2014-03-25 23:00:43

The Firm is investigating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes and other dangerous cardiovascular problems, allegedly due to the use of drugs like Testim and AndroGel. New York, New York (PRWEB) March 25, 2014 A second testosterone treatment lawsuit (http://www.testosteronelawsuitcenter.com/) has been filed in Pennsylvania on behalf of a man who allegedly suffered serious cardiovascular problems due to his use of Testim. According to the...

2014-03-24 20:23:44

The International Society on Thrombosis and Haemostasis partners with thrombosis related organizations from every continent to launch World Thrombosis Day focused on single cause of top 3 cardiovascular deaths worldwide CHAPEL HILL, N.C., March 24, 2014 /PRNewswire-USNewswire/ -- Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers - heart attack, stroke and venous...